Cargando…

Which Is the Most Appropriate PI3K Inhibitor for Breast Cancer Patients with or without PIK3CA Status Mutant? A Systematic Review and Network Meta-Analysis

OBJECTIVE: The phosphatidylinositol 3-kinase (PI3K) signaling pathway is a promising treatment target for patients with breast cancer (BC). Our study aimed to evaluate the most effective and safe PI3K inhibitor for patients with BC, especially in PIK3CA mutation. METHODS: Electronics databases were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shu, Liu, Mingyue, Lian, Siheng, Liu, Naiming, Zhang, Guibin, Zhao, Qingchun, Zhang, Yingshi, Jian, Lingyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739049/ https://www.ncbi.nlm.nih.gov/pubmed/33376736 http://dx.doi.org/10.1155/2020/7451576

Ejemplares similares

Targeting glutamine metabolism in PIK3CA mutant colorectal cancers
por: Feng, Xiujing, et al.
Publicado: (2016)

Surgical management for isolated macrodactyly in an adult PIK3CA mutant
por: Jacobs, C.J., et al.
Publicado: (2020)

Carcinogenesis of PIK3CA
por: German, Sidra, et al.
Publicado: (2013)

Effective use of PI3K inhibitor BKM120 and PARP inhibitor Olaparib to treat PIK3CA mutant ovarian cancer
por: Wang, Dong, et al.
Publicado: (2016)

Alteration of tumor associated neutrophils by PIK3CA expression in endometrial carcinoma from TCGA data
por: Pan, Yinglian, et al.
Publicado: (2019)

Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway
por: Chen, Zhihang, et al.
Publicado: (2020)

Mutant PIK3CA Induces EMT in a Cell Type Specific Manner
por: Bhagirath, Divya, et al.
Publicado: (2016)

Response of Brain Metastases From PIK3CA-Mutant Breast Cancer to Alpelisib
por: Batalini, Felipe, et al.
Publicado: (2020)

PIK3CA mutation in a case of CTNNB1-mutant sinonasal glomangiopericytoma
por: Hong, Christopher S., et al.
Publicado: (2022)

PIK3CA in Colorectal Cancer
por: Cathomas, Gieri
Publicado: (2014)

Pilot study of sirolimus in patients with PIK3CA mutant/amplified refractory solid cancer
por: Jung, Ki Sun, et al.
Publicado: (2017)

Dual blocking of PI3K and mTOR signaling by DHW‐221, a novel benzimidazole derivative, exerts antitumor activity in human non‐small cell lung cancer
por: Qin, Xiaochun, et al.
Publicado: (2021)

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
por: Chen, Li, et al.
Publicado: (2018)

Aspirin exerts high anti-cancer activity in PIK3CA-mutant colon cancer cells
por: Gu, Mancang, et al.
Publicado: (2017)

Mutations of PIK3CA in gastric adenocarcinoma
por: Li, Vivian Sze Wing, et al.
Publicado: (2005)

Mutations in PIK3CA are infrequent in neuroblastoma
por: Dam, Vincent, et al.
Publicado: (2006)

PIK3CA-mutations in breast cancer
por: Reinhardt, Kristin, et al.
Publicado: (2022)

DHW-208, A Novel Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Has Anti-Hepatocellular Carcinoma Activity Through Promoting Apoptosis and Inhibiting Angiogenesis
por: Wang, Shu, et al.
Publicado: (2022)

Nuclear translocation of p85β promotes tumorigenesis of PIK3CA helical domain mutant cancer
por: Hao, Yujun, et al.
Publicado: (2022)

Investigating the Structure and Dynamics of the PIK3CA Wild-Type and H1047R Oncogenic Mutant
por: Gkeka, Paraskevi, et al.
Publicado: (2014)

Mutation-Associated Phenotypic Heterogeneity in Novel and Canonical PIK3CA Helical and Kinase Domain Mutants
por: Ghodsinia, Arman Ali, et al.
Publicado: (2020)

Targeting the mutant PIK3CA gene by DNA‐alkylating pyrrole‐imidazole polyamide in cervical cancer
por: Krishnamurthy, Sakthisri, et al.
Publicado: (2021)

Single Nucleotide Polymorphism rs17849071 G/T in the PIK3CA Gene Is Inversely Associated with Follicular Thyroid Cancer and PIK3CA Amplification
por: Xing, Jeffrey C., et al.
Publicado: (2012)

Inhibitors of STAT3, β‐catenin, and IGF‐1R sensitize mouse PIK3CA‐mutant breast cancer to PI3K inhibitors
por: Merino, Vanessa F., et al.
Publicado: (2017)

Which is the Most Appropriate Disconnection Surgery for Refractory Epilepsy in Childhood?
por: Kishima, Haruhiko, et al.
Publicado: (2013)

Test of association: which one is the most appropriate for my study?
por: Gonzalez-Chica, David Alejandro, et al.
Publicado: (2015)

Mutation of the PIK3CA oncogene in human cancers
por: Karakas, B, et al.
Publicado: (2006)

Initiating breast cancer by PIK3CA mutation
por: Miller, Todd W
Publicado: (2012)

PIK3CA Mutations in Hepatocellular Carcinoma in Korea
por: Kim, Heesue, et al.
Publicado: (2013)

PIK3CA Mutational Analysis of Parathyroid Adenomas
por: Riccardi, Aaliyah, et al.
Publicado: (2020)

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases
por: Palimaru, Irina, et al.
Publicado: (2013)

A Mosaic PIK3CA Mutation in a Moroccan Female: Exploring the Diagnostic Challenges of PIK3CA-Related Overgrowth Spectrum
por: Ahakoud, Mohamed, et al.
Publicado: (2023)

PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro
por: Henken, Florianne E, et al.
Publicado: (2011)

PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors
por: Payne, S N, et al.
Publicado: (2015)

Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells
por: Weber, Genevieve L., et al.
Publicado: (2011)

Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells
por: Kim, Hyun-Jung, et al.
Publicado: (2016)

Describing numerical variables: which are the most appropriate parameters to describe the data?
por: Duquia, Rodrigo Pereira, et al.
Publicado: (2017)

Assessing the Effect of Mycotoxin Combinations: Which Mathematical Model Is (the Most) Appropriate?
por: Kifer, Domagoj, et al.
Publicado: (2020)

PIK3CA gene mutations in Northwest Chinese esophageal squamous cell carcinoma
por: Liu, Shi-Yuan, et al.
Publicado: (2017)

PIK3CA alterations in Middle Eastern ovarian cancers
por: Abubaker, Jehad, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_71mpbokqd9djjakhq3g0vnl428